|
 |
European Pharmaceutical Contractor
|
Are you Transferring to e-Trials?
When looking at the landscape of current clinical research we find a great mixture of companies in research, CROs as well as industry start-ups, with e-trials starting to appear more frequently.
Only very few companies have implemented electronic data capture (EDC) and electronic study management services as their standard clinical trial technology. The new technology is handed over from pilot to pilot. However wherever the EDC provider looks, companies and people are becoming ready to fully commit to e-trials in the near future.
Another look at the strange experiences relating to the introduction of electronic systems and services within clinical trials reveals that many people have used EDC once and - whilst not having a negative experience - are not convinced enough to use it in the next trial. The advantages proven and presented by vendors and suppliers often trickle away somewhere in the complex setting of a clinical trial. This is strange considering the technology to which users retreat is - in the eyes of an IT professional - extraordinarily old fashioned. The case can only be compared with travel by car being excelled by someone travelling on horseback from town to town. When looking at several years of electronic data capture we will see that this analogy is rather apt.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
